Arisinfra Solutions grants 1,633 ESOPs under 2024 plan
Arisinfra Solutions Limited granted 1,633 ESOPs under its 2024 plan on August 5, 2026. The NRC approved the awards, which carry a face value of ₹2. Exercise prices are to be determined by the Board but will not be less than face value. No options have vested or been exercised.

*this image is generated using AI for illustrative purposes only.
Arisinfra Solutions Limited has approved the grant of 1,633 Employee Stock Options (ESOPs) under its Arisinfra ESOP - 2024 scheme, signaling continued commitment to employee retention through equity incentives. The Nomination and Remuneration Committee (NRC) of the Board of Directors authorized the grants during its meeting held on Wednesday, August 05, 2026. This move aligns employee interests with shareholder value creation, a standard practice in the technology sector to mitigate talent churn.
The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026. The intimation was submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Ltd (NSE). Bhavik Jayesh Khara, Whole Time Director & CFO, signed the communication on behalf of the company.
Grant Details
The approved options represent equity shares of face value ₹2 each. While the specific exercise price is not fixed at the time of grant, it will be determined by the Board or the NRC and must not be less than the face value of the equity share as on the date of grant. Grantees will receive the specific exercise price via their Grant Letter.
| Particulars | Details |
|---|---|
| Options Granted | 1,633 |
| Face Value | ₹2 |
| Scheme | Arisinfra ESOP - 2024 |
| Vested Options | Nil |
| Options Exercised | Nil |
| Options Lapsed | Nil |
Scheme Terms
The grants are made in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Each stock option entitles the holder to apply for one equity share upon exercise. The timeline for exercising these options is governed by the terms of the Arisinfra ESOP - 2024 scheme. As of the date of this filing, no options have vested, been exercised, or lapsed. There have been no subsequent changes, cancellations, or variations to the terms of these options.
What the Numbers Show
The relatively small size of the grant — 1,633 options — suggests targeted retention efforts for key personnel rather than a broad-based incentive program. With no options currently vested, the immediate impact on diluted earnings per share is negligible. The flexibility in setting the exercise price, bounded only by the face value floor, allows management to adjust for market conditions at the time of finalization, potentially enhancing the perceived value of the award for employees.
Historical Stock Returns for Arisinfra Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.08% | +6.10% | +21.83% | +53.30% | -8.91% | -21.72% |
How might the final determination of the exercise price impact the dilution effect on existing shareholders once the options vest?
What specific key roles or departments are likely targeted by this small, focused ESOP grant to mitigate talent churn?
Could this retention strategy signal upcoming strategic initiatives or product launches that require specialized technical expertise?


































